Protech Biopharma Private Limited, a active private limited company, was established on 15 November 2007 in Srinagar, Jammu & Kashmir, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24233JK2007PTC002841. Registered under ROC Roc Jammu. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.00 M.
It upholds a compliant status. Its leadership includes Abdul Rehman Mir (Director), Nazia Dar (Director). Past directors included Shailja Nandan Mishra, Bipin Kumar Sharma, Dharmendra Mani Tripathi. It holds ₹2.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Dilkash Guest House First Floor Al Safa Market Sarai Bala, Srinagar, Jammu & Kashmir, 190001.
U24233JK2007PTC002841
002841
15 November 2007
₹2.50 M
₹2.00 M
Roc Jammu
Unlisted
Active
Explore comprehensive insights into Protech Biopharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Abdul Rehman Mir | Director | 14 Dec 2021 | Current |
| Nazia Dar | Director | 14 Dec 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Dec 2021 | Past |
| Pramod Abcsdd | Additional Director | 21 Sep 2010 | Past |
| Pramod Abcsdd | Additional Director | 30 Mar 2019 | Past |
| Pramod Abcsdd | Managing Director | 29 Mar 2018 | Past |
| Pramod Abcsdd | Director | 05 Jan 2019 | Past |
| Pramod Abcsdd | Director | 18 Dec 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Protech Biopharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 44.36% increase. The company also saw a substantial improvement in profitability, with a 22.78% increase in profit. The company's net worth moved up by a moderate rise of 7.84%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Protech Biopharma had a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹20,012,998.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jun 2025 | The Jammu And Kashmir Bank Limited | ₹0.29 M | Open |
| 09 Sep 2022 | The Jammu And Kashmir Bank Limited | ₹0.26 M | Open |
| 14 Dec 2021 | The Jammu And Kashmir Bank Limited | ₹2.60 M | Open |
| 23 Nov 2021 | Hdfc Bank Limited | ₹0.57 M | Open |
| 28 Nov 2017 | The Jammu And Kashmir Bank Limited | ₹0.30 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Protech Biopharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Protech Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Protech Biopharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with The Jammu And Kashmir Bank Limited amounted to Rs. 0.29 M with Charge ID 101175059 was registered on 30 Jun 2025. was completed.
Progress on Nazia Dar was appointed as a Director was appointed as a Director on 14 Dec 2024 & has been associated with this company since 11 months 19 days . was documented.
Progress on Protech Biopharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Protech Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jammu. was documented.
A charge with The Jammu And Kashmir Bank Limited amounted to Rs. 0.26 M with Charge ID 100628646 was registered on 09 Sep 2022. was recorded as a recent event.
A charge with The Jammu And Kashmir Bank Limited amounted to Rs. 2.60 M with Charge ID 100520367 was registered on 14 Dec 2021. was recorded as a recent event.
The CIN of Protech Biopharma Private Limited is U24233JK2007PTC002841.
Protech Biopharma Private Limited is headquartered at Dilkash Guest House First Floor Al Safa Market Sarai Bala, Srinagar, Jammu & Kashmir, 190001.
Protech Biopharma Private Limited was incorporated on 15 November 2007.
The current directors of Protech Biopharma Private Limited are
The primary industry of Protech Biopharma Private Limited is Manufacturing.
Protech Biopharma Private Limited is unlisted.
The authorized capital of Protech Biopharma Private Limited is ₹2.50 M, and the paid-up capital is ₹2.00 M.
The compliance status of Protech Biopharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX